Lucideon announced that it is investing £1.5 million to expand its headquarters to include pharmaceutical quality-control testing laboratories.
Lucideon, a global provider of materials-development technologies, testing, resource efficiency, and assurance, announced that it plans to invest £1.5 million ($2.4 million USD) to expand its headquarters in Stoke-on-Trent, England to include pharmaceutical quality-control testing laboratories.
The facilities include chemistry and microbiology laboratories for pharamcopeial testing (British Pharmacopoeia, European Pharmacopoeia, United States Pharmacopeia, and Japanese Pharacopoeia), quality control (batch release) testing, method development and validation, raw material analysis, stability storage and water testing, and microbiology determination testing including sterility, endotoxin, and bioburden.
